【摘 要】
：
BACKGROUD Bushenhuogu decoction was effective for preventing and treating osteoporosis, but the concrete mechanism of pharmacology is still not clear.25-hydroxy vitamin D and 1, 25-dihydroxyvitamin D3
【机 构】
：
Union Hospital, Tongji Medical Colleage, Huazhong University of Science and Technology
【出 处】
：
第七届国际骨质疏松及骨矿盐疾病学术会议
论文部分内容阅读
BACKGROUD Bushenhuogu decoction was effective for preventing and treating osteoporosis, but the concrete mechanism of pharmacology is still not clear.25-hydroxy vitamin D and 1, 25-dihydroxyvitamin D3 are important cytokines,which can regulate bone resorption and formation.
其他文献
Background: Osteoporosis is a common disease characterised by a systemic impairment of bone mass and microarchitecture that significantly increases the incidence of fragility fractures.The aim of this
Background: Mi-Gu Capsule (MG) is the water extract of a Chinese herbal formula Bushenfang (BSF), which composed of Herba Epimedii, Radix Polygoni, Radix Astragali, Herba Dendrobii, Herba Cistanches,
Background: Osteoporosis is a common disease among elderly people.Its main consequence is the increasing risk of bone fracture.Bone defects caused by osteoporotic fracture often require bone graft tre
Background: A major challenge faced in the bone materials of weight-bearing without internal fixture support is the mismatch of material degradation and new bone formation,leading to weakening or even
Background: Osteoporotic fractures have the characteristic of diverse and irregular fracture shape, high incidence of delayed union and nonunion, with decreased bone formation and impaired microarchit
Background: Vertebral augmentation has been widely used to treat vertebral compression fractures caused by osteoporosis, multiple myeloma, and osteolytic metastases.Biodegradable calcium phosphate cem
Background: The osteoporotic fractures are difficult to union, owing to the lack of bone formation, thus in clinic,osteogenic growth factors are urgently needed to facilitate the healing process.It ha
目的 比较老年女性严重骨质疏松有无骨折患者骨密度(面积骨密度、体积骨密度),骨转换指标和FRAX评估骨折风险概率的不同,探讨二者之间存在的差异.方法 根据我国骨质疏松诊断标准,横断面研究30例严重骨质疏松老年女性,其中骨折组与无骨折组各15例.进行问卷调查收集相关资料及基本情况筛查后,采用双能X线吸收仪(DXA)测量腰椎1～4及左髋部面积骨密度(aBMD)、单能定量CT(QCT)测量腰椎2～4及左
目的 评估绝经后女性T2DM患者未来10年内发生髓部骨折和主要骨质疏松性骨折的概率.方法 本研究为共纳入481例绝经后女性,其中T2DM住院患者298例,健康对照组183例,采用双能X线骨密度仪测定腰椎2-4(L2-4)、股骨颈(femoral neck,FN)骨密度(bone mineral density,BMD).采用FRAX中国模式计算10年内髋部骨折概率和主要骨质疏松性骨折概率.
Background: Hyperparathyroidism-jaw tumor syndrome (HPT-JT) and familial isolated primary hyperparathyroidism (FIHP) are two subtypes of familial primary hyperparathyroidism, which are rarely reported